Racehorse Drug Policies Questioned at HBPA Convention
Tracy Gantz
January 27, 2014
Some attendees suggested questionable studies might be the basis for some medication policies.
Some attendees suggested questionable studies might be the basis for some medication policies.
Officials will soon consider a penalty system for drug violations that dovetails with uniform model rules.
The cobalt was presumably used as a performance-enhancing substance, a statement said.
Get helpful information for navigating the crowded field of performance-horse medications.
Steroid scandals prompted the British Horseracing Authority to amend its medication control policy.
The booklet lists 24 therapeutic medications with their withdrawal times and threshold levels.
The KHRC approved changes to its withdrawal time guidelines for all racing breeds.
Out-of-competition drug testing has broad support, but some issues have made use difficult for regulators
The Ohio State Racing Commission indicated it’s not prepared to adopt a uniform national drug policy.
Kentucky has begun initial consideration of the reforms through its Equine Drug Research Council.
Several compounding pharmacies are under scrutiny from horse racing regulators.
The effort to adopt uniform national reforms continues to gain support, the NTRA reports.
Dressage rider Isabell Werth received a six-month suspension after her horse tested positive for cimetidine.
The United States Trotting Association (USTA) has created its own Medication Advisory Committee.
Regulators are poised to enact new thresholds for 24 drugs and propose rules to regulate shock wave therapy.
All urine and blood samples collected from Breeders’ Cup horses tested negative for prohibited substances.
Stay on top of the most recent Horse Health news with
